Dianthus Therapeutics, Inc. /DE/ (DNTH) (CIK 0001690585) CORRESP

Dianthus Therapeutics, Inc. /DE/ (DNTH) (CIK 0001690585) → SEC staff · filed 2026-01-29 · ticker DNTH · SIC 2834 · view PDF on sec.gov ↗
A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

Key facts

Accession number
0001193125-26-029517
Form
CORRESP
Filer
Dianthus Therapeutics, Inc. /DE/ (DNTH) (CIK 0001690585)
CIK
0001690585
Ticker
DNTH
Filed
2026-01-29
SIC industry
2834
HQ
New York, NY

Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/1690585/000119312526029517/filename1.htm

EDGAR review index: browse all UPLOAD/CORRESP for this filer ↗

Other comment-letter activity for this filer